These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19261668)

  • 1. Organisations question EC changes on drug information for patients.
    Watson R
    BMJ; 2009 Mar; 338():b894. PubMed ID: 19261668
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug companies and the public. EC proposal can be defeated.
    Redding D
    BMJ; 2009 Jan; 338():b291. PubMed ID: 19174441
    [No Abstract]   [Full Text] [Related]  

  • 3. EC, don't let drug companies give information to the public.
    Currie JA; Preston H; Weerapperuma S
    BMJ; 2009 Jan; 338():b290. PubMed ID: 19174440
    [No Abstract]   [Full Text] [Related]  

  • 4. [Patient education responsibility, specialty and administration information from the viewpoint of the pharmaceutical industry].
    Granitza A
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):649-53. PubMed ID: 9527462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The patient information and education initiative.
    Rheinstein PH; McGinnis TJ; Nightingale SL
    Am Fam Physician; 1995 Dec; 52(8):2377-8, 2381-2. PubMed ID: 7484726
    [No Abstract]   [Full Text] [Related]  

  • 6. [Education responsibility, specialty and administration information from the legal viewpoint].
    Schreiber HL
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):653-7. PubMed ID: 9527463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug information for patients. Duties of the manufacturer, pharmacist, physician, and hospital.
    Brushwood DB; Simonsmeier LM
    J Leg Med; 1986 Sep; 7(3):279-340. PubMed ID: 3490527
    [No Abstract]   [Full Text] [Related]  

  • 8. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
    Alván G
    Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017
    [No Abstract]   [Full Text] [Related]  

  • 9. [Can we rely on drug information?].
    Myhr K
    Tidsskr Nor Laegeforen; 2002 Nov; 122(27):2644-6. PubMed ID: 12523198
    [No Abstract]   [Full Text] [Related]  

  • 10. How to misinform patients.
    Drug Ther Bull; 2009 Aug; 47(8):85. PubMed ID: 19654416
    [No Abstract]   [Full Text] [Related]  

  • 11. [Patient education responsibility, specialty and administration information from the internal medicine viewpoint].
    Ludwig WD
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):657-61. PubMed ID: 9527464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating drug information in Europe: a pyrrhic victory for pharmaceutical industry critics?
    Mulinari S
    Sociol Health Illn; 2013 Jun; 35(5):761-77. PubMed ID: 23094890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Additional information].
    Kircher W
    Med Monatsschr Pharm; 1990 Jan; 13(1):1. PubMed ID: 2304412
    [No Abstract]   [Full Text] [Related]  

  • 14. Informing the consumer.
    Rice M
    Eur J Cancer; 2003 Feb; 39(3):271. PubMed ID: 12632579
    [No Abstract]   [Full Text] [Related]  

  • 15. Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
    Huh J; Cude BJ
    J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating manufacturer-affiliated communication in the information age.
    Schulman KA; Abernethy DR; Rathore SS; Woosley RL
    Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
    [No Abstract]   [Full Text] [Related]  

  • 17. [Patient education and specialty prescription information from the psychiatric viewpoint].
    Linden M
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):662-7; discussion 667-8. PubMed ID: 9527465
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct-to-consumer prescription drug advertising.
    Terzian TV
    Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
    [No Abstract]   [Full Text] [Related]  

  • 19. Sweetening the pill.
    Brown H
    BMJ; 2007 Mar; 334(7595):664-6. PubMed ID: 17395944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defense of the learned intermediary doctrine.
    Goetz RB; Growdon KR
    Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.